Kamada Reports Record Financial Results and Increases 2026 Annual Guidance

11/9/2026
Impact: 72
Healthcare

Kamada reported record revenue of $152.2 million for the first nine months of 2026, up 12% year over year, and adjusted EBITDA of $40.9 million. Following strong third-quarter performance, it raised 2026 guidance to revenue of $205 million–$208 million and adjusted EBITDA of $52 million–$54 million, citing portfolio strength and higher U.S. KEDRAB sales. The company declared a $0.14-per-share cash dividend, totaling about $8 million and payable December 9, 2026, and projected double-digit revenue and profitability growth in 2027.

AI summary, not financial advice

Share: